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1. INTRODUCTION
The concept of digital health is not a new or revolutionary one. For example, technologies, such as
medical images and telemedicine date back over 100 years (1, 2), while prototype wearable devices
have been used to tackle obesity since the 1940s (3). Digital health, however, has had continually
transforming effects in an industry that is notoriously resistant to change (4). Moreover, since
the mid-1990s when the US National Academy of Medicine began recommending the complete
digitization of health data (5), the transforming effects of digital technologies in healthcare has
never been more evident. With the advent of wearables and other Internet of Things (IoT) devices,
health care is moving further toward personalized and preventative paradigms utilizing ubiquitous
technologies which support real-time self-care or monitoring (6).
The ongoing coronavirus disease 2019 (COVID-19) pandemic increases the need for ongoing
digital health advancements. For example, traditional face-to-face medical consults increase the
risk of infection, emphasizing the need for virtual consultation technologies (7). Similarly, tools
are needed to help understand and support the effects of the pandemic on our physical and, in
particular, mental health (8). Even without this amplified need, it is clear that digital technologies
will continue to transform the healthcare sector again and again. As with Wilhelm Conrad
Röntgen—the physicist who discovered X-rays (1)—and many others before, contributions are
expected from individuals with technical backgrounds rather than just pure medical. Building on
from Kostkova (9), this article highlights a selection of crucial current challenges to overcome
to ensure that digital health systems to meet the guiding principle of being for all anywhere
and at anytime.
2. SOCIETAL FACTORS
While technology is at the heart of any digital health system, the related transformations cannot be
viewed purely through a technological lens (10). Digital technologies need to deliver affordable,
easy-to-use healthcare solutions to a growing and aging population in which new technologies
are often slow to be adopted and accepted by the general populace (11). Factors that influence
this lack of acceptance include regulatory factors, such as uncertainties surrounding digital health
policies and legislation as well as a perceived lack of accountability within the commercial sector.
The commercial sector itself has challenges related to the complexity of the multinational nature of
the digital health market and the need to operate within the constraints of a multitude of different
health systems. Low levels of digital and health literacy—and thus digital health literacy—in the
general population, especially in the elderly, is also a major contributing factor.
Substantial efforts, therefore, needed to be made to normalize the use of digital health at a
societal level. These efforts should include upskilling both health professional and the general
public through broad-reaching educational initiatives (11). Processes are also needed to assess
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the suitability of digital health solutions from the perspective
of all stakeholders, especially those representing the patient
and clinician end-users groups (12). To ensure wider adaption,
the next generation of digital technologies should support and
engage users in such a way that fosters equality and inclusivity,
resulting in improved healthcare solutions for all (13, 14).
COVID-19 has highlighted the need to adapt and update
clinical care delivery systems (15). Concerns have been raised
that efforts to move away from traditional face-to-face medicine
and toward remote, digital, solutions have highlighted, such
as the already existing socioeconomic gaps between groups
of people who can easily access and use such services and
those who cannot (16, 17). Social media, while playing a vital
role in supporting communication between social and family
groups during lockdowns, has also made it considerably easier to
spread medical misinformation across societies (18, 19). Societal
and governmental efforts are urgently needed to help counter
this negative phenomenon (19). Contact tracing using remote
apps has enabled mass data collection to aid public health and
research efforts (16). However, this raises concerns relating to
data ownership and other ethical concerns (16, 20).
3. ETHICAL CHALLENGES
The increasing digitization of healthcare and the growth of
mobile and IoT devices as data collection tools raises many
ethical issues. One commonly recurring theme relates to the
exact nature of the role of consumer tech companies, such
as Amazon, Apple, Google, Facebook, or Samsung, who have
all entered the digital health domain (21). In particular, such
companies offer solutions for collecting, storing and analyzing
health data which raises issues relating to privacy, data protection
and informed consent (21–23). The nature of health data is also
changing; we are now collecting more private user-generated
data, particularly data harvested from social media and through
wearable technologies, than ever before.
As well as the issues mentioned above of privacy, protection,
and consent, ethical concerns relating to data ownership are
frequently discussed in the literature [e.g., (23, 24)]. The growth
of apps and technologies developed for a consumer market
blurs the lines between what is medical and non-medical devices
and raises ethical challenges relating to how to regularize such
technologies (22, 25). This issue is exacerbated by the speed
of advancements and increasing globalization of healthcare
solutions (25, 26).
4. INCREASED CONNECTED HEALTH
SOLUTIONS
A core aim of digital health is to help facilitate the circulation
of data between patients, devices, and clinicians (27). Increasing
this connectivity enables smarter and more timely sharing of
information between clinicians and patients and has strong
links to the predictive, preemptive, and personalized principles
of digital health (28). Connected health solutions are also a key
element in response to the COVID-19 pandemic (29). However,
increased connected health solutions come with increased safety
and security concerns.
As medicine moves beyond conventional clinical-based
patient care to the personalized and preventative models offered
by digital health applications, our concepts of patient safety will
also have to change (30, 31). The current speed of technological
advances also brings with it safety concerns. There is often a
lack of quality and evidence-based research highlighting the
associated health benefits of the newest technologies. There
are also many challenges inherent in demonstrating that newer
approaches and technologies, are indeed, effective (32).
The use of IoT devices in connected health means greater
support for anywhere anytime solutions as well as real-time self-
care or monitoring (33). However, transferring data from the
point of collection, such as IoT devices, to remote serves, brings
security and privacy concerns that need to be addressed (34).
While the practices of informed consent and privacy by design
are well-established in digital health, there are still concerns
surrounding patients’ understanding of how their data is being
processed and by whom (35). An emerging trend, not just in
digital health, but in health research in general, is increased
patient engagement, treating the patient as a stakeholder in
research, not just a data source (36). The perspective of patients is
vital for gaining a real understanding of what security and privacy
mean in the context of connected health (37).
At the time of writing, there is no universally established
treatment or vaccine for COVID-19, the IoT can play a vital
role as an information source and monitoring tool during the
pandemic (38, 39) or potentially oncoming ones. Moreover,
such devices can help in efforts to nowcast events, such
as second waves via the harnessing of large amounts of
physiological and behavioral data gathered from the general
population (40). However, the collection of such data is
not enough; complimentary artificial intelligence solutions are
needed to exploit the saliency of such data (41).
5. ROLE OF ARTIFICIAL INTELLIGENCE
Artificial Intelligence can utilize data generated in digital health
systems to help with aspects in medicine, such as improved
diagnosis, selecting treatments, and predicting clinical outcomes.
The presence of AI solutions in digital health intensifies
challenges surrounding safety, explainability, and fairness (42).
In regard to safety, AI systems are held to higher perceived
safety standards than humans (43); i.e., it is less acceptable for
AI to make errors. Moreover, the risk to human life of AI-based
systems is, currently, not well-studied, and there is a lack of
standards for the verification and validation of such systems.
There are also generalization issues associated with AI models,
reproducing promising results, made on “limited” training sets,
on real-world data. A recent systematic review of deep learning
solutions in medical images found that only a minimal number
of studies in this field were of sufficient quality for clinical
implementation (44).
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With the recent introduction of the General Data Protection
Regulation (GDPR) in the European Union, clinicians and
patients have a right to understand how a particular AI
decision was reached (45). The benefits of improving trust
and transparency in AI systems will not only benefit clinicians
and patients; increased knowledge and understanding into
internal operations and decisions should also improve the overall
accuracy and generalizability of the enhanced system (46).
Therefore, for deployment in clinical settings, the next generation
of AI technologies needs to be transparent, understandable,
explainable, and fair.
Despite AI already having achieved remarkable results in a
range of health-based detection tasks, increasing explainability is
a highly non-trivial task. This difficulty arises as many of these
results have been achieved using “black-box” techniques. That
is, data is fed in, which in turn generates a predictive output,
but the system does not provide any information or inference
concerning how it arrived at the predicted value. This issue is
particularly pronounced with the increasing presence of deep
learning systems in digital health (47). Deep learningmodels have
internal connections measuring in the millions (48).
6. THE POTENTIAL OF GENOMICS
Technological advances, increasing demand, and a reduction
in costs mean that the amount of people undertaking genetic
profiles is increasing. Despite this increase in supply and
demand, outside of a handful of notable cases, such as rare
disease diagnosis and cancer screening, genetic information is
not integrated into routine medical care (49, 50). Genomics
information has the potential to make considerable gains in
data-driven, personalized care (51). For this potential to be met,
there needs to be further developments in genetic risk scores
relevant for broader clinical, and greater understandings into the
interpretation of genetic variants (49).
These two factors are, of course, interlinked. Genomics, on
one level, essentially provides information regarding “what might
happen” to an individual concerning their health (52). A key
factor in improving our understanding of this information is the
interpretation of genetic variants identified during testing. There
are many millions of these variants, and no standard definition
for all of them (50, 53). Facilitating data and computational
resource sharing are commonly identified means of closing this
knowledge gap (50). Data sharing comes with increased ethical
concerns, which have already been discussed in this article.
Genomics advancements are interlinked connected health
challenges. For truly personalized medical care, genomics
information should be combined with environmental,
behavioral, and medical history information. Moreover,
this combination of information from multiple heterogeneous
sources needs to be performed in such a way that supports,
not confounds clinicians and patients. These heterogeneous
systems are highly dynamic and will most likely require
advanced artificial intelligence paradigms to fully combine and
analyse (49, 54).
Finally, genomics will play a vital role in efforts combating
COVID-19, and any future similar pandemics. Increased
genomic sequencing capabilities, accelerated through the use of
AI, can help in the tracking of pathogens and viruses, and in
the identification of their genomic signatures (55). Improved
capabilities can also help identify genomic factors that increase
an individual’s susceptibility or resistance (56).
7. CONCLUSION
The current coronavirus disease 2019 (COVID-19) pandemic
is undoubtedly challenging conventional medical services to
their core. Digital health solutions are going to play a vital
role in fighting the pandemic and potential future ones by
enabling fundamental shifts in medical care both during the
pandemic and in the aftermath. Such advancements are not
going to come without challenges, both relating directly to
the pandemic and more broadly to the development and
implementation of new digital health solutions. Five years ago,
Multi-disciplinary Digital Health, Big Data and Public Health,
MedTech, Self-Management, and Personalized Care, mHealth
and Global Health Interventions, Evidence and Knowledge:
Semantics, Social Media, and Persuasion, Serious Health Games
and Games-Based Learning and Training, and Personal and
Population Data—To Share or Not to Share? were identified
as some of the major challenges in digital health (9). These
challenges are still very much at the forefront of digital
health research. Rather than rehashing these challenges, this
article has highlighted new concerns, with a focus on the
role of digital health concerning COVID-19 and contagious
virus diseases. By highlighting these challenges, Frontiers in
Digital Health hopes to continue the trend of publishing world-
class multi-disciplinary research addressing these and many
other challenges in this exciting and constantly evolving field
of research.
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